These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 7906412)

  • 21. Cimaterol-induced growth in rats: growth pattern and biochemical characteristics.
    Kim YS; Lee YB; Ashmore CR
    Growth Dev Aging; 1988; 52(1):41-5. PubMed ID: 3170065
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Contribution of inert mass to experimental cancer cachexia in rats.
    Morrison SD; Moley JF; Norton JA
    J Natl Cancer Inst; 1984 Oct; 73(4):991-8. PubMed ID: 6592392
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cancer cachexia, malnutrition, and tissue protein turnover in experimental animals.
    Tessitore L; Costelli P; Bonetti G; Baccino FM
    Arch Biochem Biophys; 1993 Oct; 306(1):52-8. PubMed ID: 8215420
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Role of NF-kappa B in cancer cachexia].
    Zhou W; Jiang ZW; Jiang J; Li N; Li JS
    Zhonghua Wai Ke Za Zhi; 2004 Jun; 42(11):683-6. PubMed ID: 15329260
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of insulin in development of cancer cachexia in nongrowing sarcoma-bearing mice: special reference to muscle wasting.
    Svaninger G; Drott C; Lundholm K
    J Natl Cancer Inst; 1987 May; 78(5):943-50. PubMed ID: 3553691
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Indomethacin and ibuprofen preserve gastrocnemius muscle mass in mice bearing the colon-26 adenocarcinoma.
    McCarthy DO; Whitney P; Hitt A; Al-Majid S
    Res Nurs Health; 2004 Jun; 27(3):174-84. PubMed ID: 15141370
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Are peroxisome proliferator-activated receptors involved in skeletal muscle wasting during experimental cancer cachexia? Role of beta2-adrenergic agonists.
    Fuster G; Busquets S; Ametller E; Olivan M; Almendro V; de Oliveira CC; Figueras M; López-Soriano FJ; Argilés JM
    Cancer Res; 2007 Jul; 67(13):6512-9. PubMed ID: 17616713
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Muscle protein waste in tumor-bearing rats is effectively antagonized by a beta 2-adrenergic agonist (clenbuterol). Role of the ATP-ubiquitin-dependent proteolytic pathway.
    Costelli P; García-Martínez C; Llovera M; Carbó N; López-Soriano FJ; Agell N; Tessitore L; Baccino FM; Argilés JM
    J Clin Invest; 1995 May; 95(5):2367-72. PubMed ID: 7738199
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protein metabolism in cachectic tumor-bearing rats: effect of tumor excision.
    Le Bricon T; Cynober L; Baracos VE
    J Surg Res; 1996 Jan; 60(1):207-15. PubMed ID: 8592416
    [TBL] [Abstract][Full Text] [Related]  

  • 30. NTP Toxicology and Carcinogenesis Studies of Theophylline (CAS No. 58-55-9) in F344/N Rats and B6C3F1 Mice (Feed and Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1998 Aug; 473():1-326. PubMed ID: 12571677
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cachectin/tumor necrosis factor: a possible mediator of cancer anorexia in the rat.
    Stovroff MC; Fraker DL; Swedenborg JA; Norton JA
    Cancer Res; 1988 Aug; 48(16):4567-72. PubMed ID: 3165053
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anabolic impact of cimaterol in conjunction with enteral nutrition following burn trauma.
    Nelson JL; Chalk CL; Warden GD
    J Trauma; 1995 Feb; 38(2):237-41. PubMed ID: 7869443
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reduction of gut hypoplasia and cachexia in tumor-bearing rats maintained on total parenteral nutrition and treated with peptide YY and clenbuterol.
    Chance WT; Zhang X; Zuo L; Balasubramaniam A
    Nutrition; 1998 Jun; 14(6):502-7. PubMed ID: 9646290
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of insulin on survival of cachectic tumor-bearing rats.
    Peacock JL; Norton JA
    JPEN J Parenter Enteral Nutr; 1988; 12(3):260-4. PubMed ID: 3392822
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clenbuterol plus acivicin decrease tumor growth and increase muscle mass in rats maintained on total parenteral nutrition.
    Chance WT; Cao L; Zhang FS; Fischer JE
    Am J Surg; 1991 Jan; 161(1):51-6. PubMed ID: 1899011
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Insulin-like growth factor I preserves host lean tissue mass in cancer cachexia.
    Ng EH; Rock CS; Lazarus DD; Stiaino-Coico L; Moldawer LL; Lowry SF
    Am J Physiol; 1992 Mar; 262(3 Pt 2):R426-31. PubMed ID: 1373040
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Growth hormone, insulin, and somatostatin therapy of cancer cachexia.
    Bartlett DL; Charland S; Torosian MH
    Cancer; 1994 Mar; 73(5):1499-504. PubMed ID: 7906609
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Stimulation of tissue lipoprotein lipase activity in cancer cachectic rats: preliminary report].
    Nomura K; Noguchi Y; Yoshikawa T; Fukuzawa K; Tuburaya A; Yoshida S; Matsumoto A
    Nihon Geka Gakkai Zasshi; 1993 Jul; 94(7):759. PubMed ID: 8361478
    [No Abstract]   [Full Text] [Related]  

  • 39. Preoperative insulin reverses cachexia and decreases mortality in tumor-bearing rats.
    Moley JF; Morrison SD; Norton JA
    J Surg Res; 1987 Jul; 43(1):21-8. PubMed ID: 3599982
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Morphological alterations in the hepatocytes of tumor-bearing, cachectic rats: preliminary report].
    Makino T; Noguchi Y; Nomura K; Fukuzawa K; Matsumoto A; Ito T; Kanisawa M
    Nihon Geka Gakkai Zasshi; 1993 Feb; 94(2):196. PubMed ID: 8464421
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.